Literature DB >> 9564679

Psychometric adequacy of the Tinnitus Handicap Inventory (THI) for evaluating treatment outcome.

C W Newman1, S A Sandridge, G P Jacobson.   

Abstract

This study assessed the test-retest reliability/repeatability and 95 percent confidence intervals (CIs) of the Tinnitus Handicap Inventory (THI) and developed categories for classifying self-perceived tinnitus handicap severity. Twenty-nine adults with tinnitus as their primary auditory complaint served as subjects. The THI was administered on two occasions (mean interval 20 days) using a paper-pencil format. Results support the contention that the THI is psychometrically robust. Specifically, the test-retest reliability/repeatability was high. Additionally, the 95 percent CI for the THI was 20-points, indicating that a 20-point or greater change had to occur from test to retest for a change to be considered statistically significant at the 5 percent confidence level. Quartiles calculated from raw scores were used to create a matrix of values representing tinnitus severity. We conclude that the THI is a brief, easily administered, and psychometrically robust measure that evaluates the impact of tinnitus on daily living.

Entities:  

Mesh:

Year:  1998        PMID: 9564679

Source DB:  PubMed          Journal:  J Am Acad Audiol        ISSN: 1050-0545            Impact factor:   1.664


  112 in total

1.  Investigating long-term effects of cochlear implantation in single-sided deafness: a best practice model for longitudinal assessment of spatial hearing abilities and tinnitus handicap.

Authors:  Brian C Gartrell; Heath G Jones; Alan Kan; Melanie Buhr-Lawler; Samuel P Gubbels; Ruth Y Litovsky
Journal:  Otol Neurotol       Date:  2014-10       Impact factor: 2.311

2.  Phase I trial of caudate deep brain stimulation for treatment-resistant tinnitus.

Authors:  Steven W Cheung; Caroline A Racine; Jennifer Henderson-Sabes; Carly Demopoulos; Annette M Molinaro; Susan Heath; Srikantan S Nagarajan; Andrea L Bourne; John E Rietcheck; Sarah S Wang; Paul S Larson
Journal:  J Neurosurg       Date:  2019-09-24       Impact factor: 5.115

Review 3.  Drug-Induced Ototoxicity: Diagnosis and Monitoring.

Authors:  Kathleen C M Campbell; Colleen G Le Prell
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

4.  Tinnitus outcomes assessment.

Authors:  Mary B Meikle; Barbara J Stewart; Susan E Griest; James A Henry
Journal:  Trends Amplif       Date:  2008-07-03

5.  Tinnitus, Traumatic Brain Injury, and Posttraumatic Stress Disorder in the Military.

Authors:  John C Moring; Alan L Peterson; Kathryn E Kanzler
Journal:  Int J Behav Med       Date:  2018-06

6.  Non-penetrating round window electrode stimulation for tinnitus therapy followed by cochlear implantation.

Authors:  Gentiana I Wenzel; Petra Sarnes; Athanasia Warnecke; Timo Stöver; Burkard Jäger; Anke Lesinski-Schiedat; Thomas Lenarz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-06       Impact factor: 2.503

7.  Preoperative audiovestibular handicap in patients with vestibular schwannoma.

Authors:  Rachel L Humphriss; David M Baguley; Patrick R Axon; David A Moffat
Journal:  Skull Base       Date:  2006-11

8.  Using therapeutic sound with progressive audiologic tinnitus management.

Authors:  James A Henry; Tara L Zaugg; Paula J Myers; Martin A Schechter
Journal:  Trends Amplif       Date:  2008-07-29

9.  The Emotional and Functional Impact of the Type of Tinnitus Sensation.

Authors:  John Moring; Anne Bowen; Jenifer Thomas; Lindsay Bira
Journal:  J Clin Psychol Med Settings       Date:  2016-09

10.  Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative meeting, Regensburg, July 2006.

Authors:  B Langguth; R Goodey; A Azevedo; A Bjorne; A Cacace; A Crocetti; L Del Bo; D De Ridder; I Diges; T Elbert; H Flor; C Herraiz; T Ganz Sanchez; P Eichhammer; R Figueiredo; G Hajak; T Kleinjung; M Landgrebe; A Londero; M J A Lainez; M Mazzoli; M B Meikle; J Melcher; J P Rauschecker; P G Sand; M Struve; P Van de Heyning; P Van Dijk; R Vergara
Journal:  Prog Brain Res       Date:  2007       Impact factor: 2.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.